XML 64 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies - Additional Information (Details)
1 Months Ended 12 Months Ended
Feb. 01, 2023
USD ($)
Jan. 31, 2023
USD ($)
Oct. 01, 2022
USD ($)
Oct. 01, 2021
USD ($)
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
reporting_unit
segment
$ / shares
shares
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2016
shares
Dec. 31, 2019
USD ($)
Jan. 25, 2016
$ / shares
Summary of Significant Accounting Policies [Line Items]                      
Cash and cash equivalents and restricted cash         $ 1,348,845,000 $ 1,348,845,000 $ 1,528,259,000 $ 648,738,000   $ 82,180,000  
Net loss           (657,939,000) (1,743,751,000) (418,259,000)      
Net cash provided by (used in) operating activities           (415,937,000) 322,946,000 (42,541,000)      
Collaboration agreement upfront payment amount         819,000,000 819,000,000          
Advertising costs           $ 84,000,000 8,900,000        
Number of reporting units | reporting_unit           1          
Impairment to goodwill     $ 0 $ 0              
Income tax expense           $ 4,292,000 29,215,000 0      
Foreign currency translation adjustment         (6,400,000) (6,400,000) (1,400,000)        
Foreign currency transaction (losses) gain           $ (2,500,000) $ (5,300,000) $ 9,600,000      
Number of operating segments | segment           1          
Gavi Advance Purchase Agreement- COVAX Facility                      
Summary of Significant Accounting Policies [Line Items]                      
Collaboration agreement upfront payment amount         697,400,000 $ 697,400,000          
Government Contract | USG Agreement                      
Summary of Significant Accounting Policies [Line Items]                      
Research and development arrangement, contract to perform for others, contract remaining         416,000,000 $ 416,000,000          
5.00% Convertible notes due 2027 | Unsecured Debt                      
Summary of Significant Accounting Policies [Line Items]                      
Sale of common stock and issuance debt         $ 236,200,000            
Number of shares issued for debt converted (in shares) | shares           16,400,000          
Debt instrument, convertible, conversion price (in usd per share) | $ / shares         $ 12.50 $ 12.50          
3.75% Convertible notes due 2023 | Unsecured Debt                      
Summary of Significant Accounting Policies [Line Items]                      
Number of shares issued for debt converted (in shares) | shares           16,400,000     2,385,800    
Debt instrument, convertible, conversion price (in usd per share) | $ / shares         $ 136.20 $ 136.20         $ 136.20
3.75% Convertible notes due 2023 | Unsecured Debt | Subsequent Event                      
Summary of Significant Accounting Policies [Line Items]                      
Repayments of debt $ 325,000,000 $ 325,000,000                  
Minimum                      
Summary of Significant Accounting Policies [Line Items]                      
Requisite service period           1 year          
Maximum                      
Summary of Significant Accounting Policies [Line Items]                      
Requisite service period           4 years